Literature DB >> 34099890

Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection.

Hao Wang1, Yu Yuan1, Mingzhong Xiao2,3,4, Li Chen5,6, Youyun Zhao2,3,4, Pinpin Long1, Yana Zhou2,3,4, Xi Xu2,3,4, Yanshou Lei1, Tingyue Diao1, Hao Cai1, Li Liu1, Zuoyu Shao2,3,4, Jingzhi Wang2,3,4, Yansen Bai1, Kai Wang1, Miao Peng2,3,4, Linlin Liu7, Shi Han7, Fanghua Mei7, Kun Cai7, Yake Lei7, An Pan1, Chaolong Wang1, Rui Gong8, Xiaodong Li9,10,11, Tangchun Wu12.   

Abstract

Entities:  

Year:  2021        PMID： 34099890     DOI： 10.1038/s41423-021-00708-6

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  13 in total

Review 1.  Point-of-care diagnostics: recent developments in a pandemic age.

Authors:  Harshit Harpaldas; Siddarth Arumugam; Chelsey Campillo Rodriguez; Bhoomika Ajay Kumar; Vivian Shi; Samuel K Sia
Journal:  Lab Chip       Date:  2021-11-25       Impact factor: 6.799

2.  Longitudinal kinetics of RBD+ antibodies in COVID-19 recovered patients over 14 months.

Authors:  Tsuf Eyran; Anna Vaisman-Mentesh; David Taussig; Yael Dror; Ligal Aizik; Aya Kigel; Shai Rosenstein; Yael Bahar; Dor Ini; Ran Tur-Kaspa; Tatyana Kournos; Dana Marcoviciu; Dror Dicker; Yariv Wine
Journal:  PLoS Pathog       Date:  2022-06-03       Impact factor: 7.464

3.  Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab.

Authors:  Nathalie Van der Moeren; Philippe Selhorst; My Ha; Laura Heireman; Pieter-Jan Van Gaal; Dimitri Breems; Pieter Meysman; Kris Laukens; Walter Verstrepen; Natasja Van Gasse; Benson Ogunjimi; Kevin K Arien; Reinout Naesens
Journal:  Viruses       Date:  2022-04-03       Impact factor: 5.818

4.  SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan.

Authors:  Wendelin Moser; Mohammed Ahmed Hassan Fahal; Elamin Abualas; Shahinaz Bedri; Mahgoub Taj Elsir; Mona Fateh El Rahman Omer Mohamed; Abdelhalim Babiker Mahmoud; Amna Ismail Ibrahim Ahmad; Mohammed A Adam; Sami Altalib; Ola Adil DafaAllah; Salahaldin Abdallah Hmed; Andrew S Azman; Iza Ciglenecki; Etienne Gignoux; Alan González; Christine Mwongera; Manuel Albela Miranda
Journal:  Emerg Infect Dis       Date:  2022-05       Impact factor: 6.883

5.  Exploring Rapid and Effective Screening Methods for Anti-SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Longitudinal Vaccinated Populations.

Authors:  Caiqin Hu; Dan Li; Zhanmou Liu; Li Ren; Junwei Su; Meiling Zhu; Yi Feng; Zheng Wang; Qiang Liu; Biao Zhu; Yiming Shao
Journal:  Pathogens       Date:  2022-01-27

6.  Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19.

Authors:  Xixi Jing; Min Xu; Deye Song; Tingting Yue; Yali Wang; Pan Zhang; Yanjun Zhong; Min Zhang; Tommy Tsan-Yuk Lam; Nuno Rodrigues Faria; Erik De Clercq; Guangdi Li
Journal:  Immun Ageing       Date:  2022-03-05       Impact factor: 6.400

7.  Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection.

Authors:  Li-Na Yan; Pan-Pan Liu; Xu-Gui Li; Shi-Jing Zhou; Hao Li; Zhi-Yin Wang; Feng Shen; Bi-Chao Lu; Yu Long; Xiao Xiao; Zhen-Dong Wang; Dan Li; Hui-Ju Han; Hao Yu; Shu-Han Zhou; Wen-Liang Lv; Xue-Jie Yu
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

8.  Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection.

Authors:  Indrė Kučinskaitė-Kodzė; Martynas Simanavičius; Aistis Šimaitis; Aurelija Žvirblienė
Journal:  Viruses       Date:  2021-11-19       Impact factor: 5.048

9.  Two-years antibody responses following SARS-CoV-2 infection in humans: A study protocol.

Authors:  Eggi Arguni; Fatwa Sari Tetra Dewi; Jajah Fachiroh; Dewi Kartikawati Paramita; Septi Kurnia Lestari; Bayu Satria Wiratama; Annisa Ryan Susilaningrum; Bara Kharisma; Yogi Hasna Meisyarah; Merlinda Permata Sari; Zakiya Ammalia Farahdilla; Siswanto Siswanto; Muhammad Farhan Sjaugi; Teguh Haryo Sasongko; Lutfan Lazuardi
Journal:  PLoS One       Date:  2022-08-16       Impact factor: 3.752

10.  Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection.

Authors:  Theano Lagousi; John Routsias; Maria Mavrouli; Ioanna Papadatou; Maria Geropeppa; Vana Spoulou
Journal:  Vaccines (Basel)       Date:  2022-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.